Literature DB >> 10793051

Spontaneous improvement in a case of C1q nephropathy.

M Nishida1, H Kawakatsu, H Komatsu, K Ishiwari, M Tamai, T Sawada.   

Abstract

A 17-year-old girl showed mild proteinuria accompanied by hematuria and mild hypocomplementemia. A light microscopic study of the first renal biopsy specimen showed diffuse mild to moderate mesangial proliferation and thickening of the glomerular basement membrane (GBM). An immunofluorescence study showed dominant positive staining (3+) of IgG and C1q in the glomerular mesangium and capillary loop. Staining for C3 and fibrinogen was weak or 1+. Staining for IgA and IgM was negative. Electron-dense deposits were present in the mesangial area and also in the subepithelial, subendothelial, and intramembranous space. Urinary findings improved after dipyridamole treatment. The second renal biopsy, which was performed 5 years later, showed histological improvements, and various pictures of washing-out of deposits were also noted in an electron microscopic study. However, dominant positive staining for IgG and C1q was persistent in an immunofluorescence study. The glomerulopathy of this case belongs in the criteria of neither membranoproliferative glomerulonephritis nor lupus nephritis but could be designated as C1q nephropathy. This is the first report of a histological improvement in C1q nephropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10793051     DOI: 10.1016/s0272-6386(00)70287-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

2.  C1q nephropathy with asymptomatic urine abnormalities.

Authors:  Masashi Nishida; Hidekazu Kawakatsu; Yasuko Okumura; Kenji Hamaoka
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

3.  Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.

Authors:  Takashi Takei; Mitsuyo Itabashi; Takahito Moriyama; Ari Shimizu; Yuki Tsuruta; Ayami Ochi; Kayu Nakayama; Chihiro Iwasaki; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-07-21       Impact factor: 2.801

4.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

5.  Pathology, clinical presentations, and outcomes of C1q nephropathy.

Authors:  Alenka Vizjak; Dusan Ferluga; Mojca Rozic; Anastazija Hvala; Jelka Lindic; Tanja Kersnik Levart; Vesna Jurcić; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

6.  C1q nephropathy in a child with a chromosome 13 deletion.

Authors:  Isabel Roberti; Sachin Sachdev; Adam Aronsky; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

7.  C1q nephropathy in a patient with Gitelman syndrome.

Authors:  Consolación Rosado Rubio; Pilar Fraile Gómez; María Asunción Gómez Muñoz; Pedro Garcia-Cosmes; José Luis Lerma Márquez
Journal:  NDT Plus       Date:  2011-09-06

8.  Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis.

Authors:  Tibor Tibor Fülöp; Éva Csongrádi; Anna A Lerant; Matthew Lewin; Jack R Lewin
Journal:  J Nephropathol       Date:  2015-04-01

Review 9.  Diverse clinical and histology presentation in c1q nephropathy.

Authors:  Pavan Malleshappa; Mahesha Vankalakunti
Journal:  Nephrourol Mon       Date:  2013-06-25

Review 10.  C1q Nephropathy: The Unique Underrecognized Pathological Entity.

Authors:  Joe Devasahayam; Gowrishankar Erode-Singaravelu; Zeenat Bhat; Tony Oliver; Arul Chandran; Xu Zeng; Paramesh Dakshinesh; Unni Pillai
Journal:  Anal Cell Pathol (Amst)       Date:  2015-11-10       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.